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A B S T R A C T
Helicobacter pylori (H. pylori) is a human pathogen aﬀecting over 50% of the world population. This pathogen is
usually associated with chronic inﬂammation of the gastric mucosa that can lead to peptic ulcer disease (PUD)
and gastric cancer (GC), especially in susceptible individuals. These outcomes have been attributed to the in-
teraction of several factors, including host genetic susceptibility, local innate and adaptive immune responses,
virulence factors of H. pylori, and environmental factors. T helper (Th) cell subsets and their signature cytokines
especially IFN-γ, contribute to anti-bacterial response, but at the mean time sustaining chronic inﬂammatory
responses in the site of infection. It has been acknowledged that H. pylori-infection results in a Th1-dominant
response and that inﬂammation of the gastric mucosa depends mainly on Th1 cell responses. But, the mechanism
of the role of Th1 cell responses in H. pylori-infection has not yet been clearly explained. In this review, we will
focus on the role of Th1 involved in H. pylori-infection, its interaction with Th17/Treg cells and its association
with the clinical consequences of the infection.
1. Introduction
Helicobacter pylori (H. pylori) is a microaerophilic gram-negative
bacillus, spiral-shaped, ﬂagellated bacterium which colonizes the gas-
tric mucosa in over 50% of the world's human population [1]. H. pylori
infection is typically acquired in early childhood. Despite triggering
vigorous host innate and adaptive immune responses, H. pylori can
persist in the human gastric mucosa for decades [2]. This bacterial
pathogen plays an important role in the development of gastritis dis-
ease, peptic ulcer disease (PUD), gastric cancer (GC) and gastric mu-
cosa-associated lymphoid tissue lymphoma (GALT) [3–6]. These dif-
ferent clinical outcomes have been attributed to the interaction of
several factors, including virulence factors of H. pylori, host genetic
susceptibility, local innate and adaptive immune responses, and en-
vironmental factors (e.g., high dietary salt intake, malnutrition,
smoking, antioxidants, and vitamin deﬁciency) [7–9]. Gastric Coloni-
zation by H. pylori causes an inﬂammatory response and recruits host
immune system cells such as dendritic cells (DC), macrophages, neu-
trophils, and lymphocytes, to the gastric mucosa [10]. The exact me-
chanisms by which the H. pylori infection induced immune response
contribute to gastrointestinal mucosal damage remains to be adequately
elucidated. However, many studies have demonstrated that immune
response and cytokines contribute to controlling the infection and
sustaining the development of the chronic inﬂammation [1]. Therefore,
this review study was aimed to provide the most important ﬁndings
about the role of Th1-mediated cytokines in diﬀerent clinical expres-
sions of H. pylori infection.
2. Subpopulations of T CD4 cells
T helper (Th) cells are thought to diﬀerentiate into four major CD4+
functional classes, with distinct cytokine secretion phenotypes each of
which elicit unique functional characteristics for each type (summar-
ized in Fig. 1).
2.1. Th1 cells
Interleukin (IL)-12 is produced primarily by pathogen-activated
antigen-presenting cells, particularly DC, macrophages, and neu-
trophils. IL-12 is involved in the diﬀerentiation of naive helper T cells
into Th1 cells [11]. Th1 cells produce a set of cytokines including in-
terferon gamma (IFN-γ) and IL-2 [12]. Th1 cells generate cell-mediated
immunity, which is important with respect to protection against in-
tracellular infections. Moreover, the key Th1 transcription factors are
signal transducer and activator of transcription 4 (STAT4) and T-bet
[13].
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2.2. Th2 cells
IL-4 is a cytokine that induces diﬀerentiation of naive helper T cells
to Th2 cells. Th2 cells produce a set of cytokines including IL-4 IL-5, IL-
10, and IL-13 [12,14]. Th2 responses are associated with humoral im-
munity and protection against intestinal helminthes. Moreover, Th2
diﬀerentiation is regulated by GATA-3 [13].
2.3. Th17 cells
The cytokines transforming growth factor beta (TGF-β), IL-1β, IL-6
and IL-23 are involved in the diﬀerentiation of naive T cells into
Th17 cells in mice and humans [15]. Th17 cells have been identiﬁed as
a distinct Th cell subpopulation and a novel Th lineage mediating im-
mune response in both animal models and humans [16]. Th17 cells
mainly produce IL-17 A, which could be promoted by IL-23 in vitro [17]
and in vivo [18]. IL-17 A induces expression of chemokines that are
neutrophil chemoattractants from epithelial cells and ﬁbroblasts, in-
cluding IL-8 [19,20]. IL-17 producing cells have been shown to be
important for protection against a number of diﬀerent bacterial and
fungal infections [19,21]. In addition to IL-17 A, Th17 cells can secrete
IL-17 F, IL-21, and IL-22 [22], which can induce massive tissue reac-
tions by promoting the recruitment of inﬂammatory cells [23], while
IL-22 shows speciﬁc biological properties, such as tissue repairing and
wound healing [24].
2.4. Regulatory T cells (Tregs)
TGF-β is a cytokine that induces diﬀerentiation of naive helper T
cells to Treg cells [25]. Tregs, formerly known as suppressor T cells,
comprise a subpopulation of T cells which modulate the immune
system. Tregs are usually characterized by expression of CD4, high le-
vels of CD25, and the transcription factor forkhead box P3 (FOXP3). It
is well characterized that Tregs play crucial role in maintaining self-
tolerance and control of autoimmune diseases in both mice and humans
[1]. Tregs depending on their maturation sites, can be divided into two
subgroups, natural Tregs (nTreg) and inducible Tregs (iTreg) [26].
nTregs are developed during normal T-cell maturation in the thymus
and enter peripheral tissues where they suppress the activation of self-
reactive T cells [26]. The iTregs are directly developed in the peripheral
lymphoid organs from naive T cells after antigen priming. Several ac-
tion mechanisms by which Treg cells control the immune response have
been reported: (1) inhibition by production of immunosuppressive cy-
tokines such as IL-10, TGF-β and IL-35; (2) inhibition by cytolysis of
eﬀector cell by producing granzyme-A and granzyme-B-dependent and
perforin-dependent; (3) suppression by metabolic disruption, including
an inhibition of the proliferative response via IL-2 receptor, cyclic AMP
(cAMP)-mediated inhibition, and CD39-and/or CD73-generated, im-
munomodulation mediated by the A2 adenosine receptor; (4) interac-
tion with DC that modulates their function and maturation [27,28].
3. Virulence factors of bacterial and interaction with the host
immune cell components
3.1. The cytotoxin associated gene A (cagA)
H. pylori strains are divided into two main subpopulations based on
their capability to produce a 120–145-kDa immunodominant protein
called the cagA antigen. The cagA gene that encodes cagA is localized at
one end of the cag pathogenicity island (cag-PAI), a 40 kb DNA segment
that is most likely incorporated into the H. pylori genome through
horizontal transfer state [29,30]. The cag PAI DNA segment possesses
approximately 27–31 putative genes, including cagA and those en-
coding the components of a molecular syringe called type IV secretion
system (T4SS), through which macromolecules are delivered from the
inside to the outside of the bacterium [31,32]. The cagL gene, which is
also located in the cagPAI, encodes the CagL protein. CagL is expressed
on the surface of H. pylori in a T4SS-dependent manner [33].
The T4SS usually comprises a set of 12 proteins (VirB1-11 and
VirD4), of which VirD4 (HP0524) acts as a coupling protein that recruits
substrates to the T4SS apparatus. The H. pylori VirD4 acts as an adaptor
protein for the transfer of the CagA protein and possibly other unknown
proteins into the host cells [34]. Upon the attachment of cagA-positive
H. pylori to the gastric epithelial cell, the CagA protein is injected di-
rectly into the cell [35]. Upon injection, unphosphorylated CagA in-
teracts with host cell proteins. This causes dysregulation of epithelial
structure and integrity through its eﬀect on host cell signaling and in-
duction of pro-inﬂammatory and mitogenic responses [36–38].
CagA is not only injected into gastric epithelial cells but also in-
jected into B lymphoid cells and murine and human DCs [39–41].
Fig. 1. Complex network of cytokines and transcription factors for generation and function of the T CD4+ cell subpopulation.
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Remarkably, CagA translocation into DCs suppresses host immune re-
sponse by reducing the secretion of pro-inﬂammatory cytokines such as
IL-12p40 and enhancing the expression of the suppressive cytokine IL-
10. This indicates a dual pro- and anti-inﬂammatory role for CagA
during H. pylori infection which is dependent on the cellular context
[41,42].
More recent data have demonstrated rapid maturation and activa-
tion of monocyte-derived DCs by intact H. pylori [43,44]. DC activation
is accompanied by expression of high levels of IL-12 and low levels of
IL-10, which should favor a Th1-type T-cell response. In vitro study by
guiney et al. suggested that the products of the cag pathogenicity island
may be involved in the activation of IL-12 expression because IL-12
expression is reduced by 50% when an isogenic cagE mutant is used
[43]. Another factor, which may be involved in IL-12 induction, in-
cludes products of the genes in the H. pylori plasticity region [45], a
region of the genome with substantial strain variation.
In addition, H. pylori-pulsed DCs cause activation of naive auto-
logous T cells and expression of IL-2, tumor necrosis factor alpha (TNF-
α), and IFN-γ but not IL-4 [44]. These data indicate that H. pylori
virulence factors inﬂuence DC activation and maturation in a way that
Th1 polarization is driven. This data might explain, at least in part, the
Th1 polarization observed in the gastric mucosa of H. pylori-infected
individuals.
3.2. The vacuolating cytotoxin A (vacA)
The vacA gene, which is an important H. pylori virulence factor
present in all strains, and encodes an 87 kD protein. The initial studies
on vacA have detected two main polymorphic regions including the
signal sequence (s1 and s2) and two middle regions (m1 and m2).
However, the more recently studies have identiﬁed two intermediate
regions (i1 and i2) which are located between the s and m regions [46].
The mosaic combination of s and m region allelic types determines the
production of the cytotoxin and is associated with pathogenicity of the
bacteria [47].
VacA is considered a H. pylori toxin with multiple cellular eﬀects in
various host cell types. The toxin inserts into the cell membrane and
forms anion-conducting channels. This seems to be important for the
modulation of other vacA activities including the ability to induce large
acidic vacuoles, which is the ﬁrst epithelial cell phenotype attributed to
the toxin [48–50]. The VacA toxin interferes with autophagy pathways
of gastric cells, causes gastric epithelial erosions in mice, induces cell
apoptosis, and causes cell necrosis. It also has immunomodulatory
properties by inhibiting T- and B-lymphocyte proliferation and activa-
tion [7,51]. VacA, through an unknown mechanism, has also an in-
direct eﬀect on T cells. It can induce DC tolerance and regulatory T cell
induction; however, this eﬀect has not yet been documented in human
cells [52,53]. VacA also induces a proinﬂammatory eﬀect on T cells that
is mediated by activation of NF-kB and leads to upregulation of IL-8
[54].
3.3. The H. pylori neutrophil-activating protein (HP-NAP)
The gene, napA, encoding the neutrophil-activating protein of H.
pylori (HP-NAP, or denoted as NapA) has been detected in all H. pylori
isolates from infected patients. H. pylori-NAP is classiﬁed as a protein
virulence factor of H. pylori that can stimulate neutrophils to generate
reactive oxygen species (ROS) when this pathogen adheres to en-
dothelial cells. This 17-kDa protein is known as a major antigen in the
human immune response to H. pylori-infection [55]. H. pylori-NAP
through binding to both neutrophil glycosphingolipids and mucin, can
mediate neutrophil adhesion to endothelial cells [56] and play an im-
portant role in recruiting human monocytes and neutrophils to the site
of H. pylori infection [57,58].
The role of H. pylori-NAP in triggering cell-mediated immune re-
sponse has also been shown before [59–61]. It has been shown that H.
pylori-NAP can induce the innate immune cells including monocytes
and neutrophils to produce IL-23 and IL-12 and elicit an antigen-spe-
ciﬁc Th1-polarized T-cell response in the gastric mucosa of H. pylori-
infected patients [59–61]. In this context, H. pylori-NAP induces
monocytes to express IL-23 and to diﬀerentiate into DC [60]. Moreover,
it stimulates macrophages to express the MHC-II [62]. Thus, H. pylori-
NAP is expected to be capable of promoting the induction of Th1 cell
responses in H. pylori-infected patients. Furthermore, addition of H.
pylori-NAP into culture of T cell lines, as an immune modulator, re-
sulted in a remarkable increase in the number of IFN-γ producing T cells
and in adverse, decrease of IL-4 secreting cells. Thus, H. pylori-NAP
promotes shifting the cytokine proﬁle of antigen-activated human T
cells from Th2 to a Th1 cytotoxic phenotype [60].
Induction of the Th1 cell response by H. pylori-NAP may also con-
tribute to the pathogenesis of H. pylori infection. The models of how H.
pylori-NAP exerts its pathological eﬀects by secreting pro-inﬂammatory
cytokines, promoting leukocyte recruitment, and subsequently stimu-
lating its immunomodulating activity have been well clariﬁed in the
other reviews [63].
4. The role of macrophages in induction of Th1 cell responses in
H. pylori-infection
Macrophage activation is a critical constituent of the host immune
response to H. pylori-infection [64]. There are diﬀerent types of mac-
rophages including M1 (inﬂammatory macrophages), M2 (remodeling/
ﬁbrotic), and Mreg (resolving/immune-regulatory) [65]. The M1 mac-
rophages are characterized by proinﬂammatory cytokines (such as TNF-
α and IL-6) secretion and production of nitric oxide (NO) synthase
(NOS). Activation of M1 macrophages can result in an eﬀective pa-
thogen killing mechanisms [65,66]. Alternatively, activated M2 mac-
rophages are specialized for responses to parasites and wound healing,
with enhanced expression of resistin-like molecule alpha (RETNLA),
arginase 1 (ARG1), and chitinase 1 (CHIA1) [65]. The M2 macrophages
are also referred to as tumor-associated macrophages, given their an-
giogenic and chemotactic stimuli and tumorigenic properties [67]. The
Mreg macrophages secret high levels of anti-inﬂammatory cytokines
like IL-10 and TGF-β (Fig. 2) [65,66]. Recent studies have shown that
H. pylori infection most often results in M1 and Mreg macrophage ac-
tivation [68,69]. It has been shown that Macrophages respond to H.
pylori-derived products and signals from gastric epithelial cells, which
are in direct contact with the bacterium. Available data suggest that
recruited macrophages and monocytes in the site of infection can pro-
duce IL-12, by which stimulate Th1 cells and result in production of
cytokines such as IFN-γ [70,71].
5. Th1-cells, cross talk with Th17 and Tregs, and induction of
gastritis
Because most infected patients with H. pylori are unable to clear the
pathogen, it has been suspected that H. pylorimay somehow hamper the
host immune response. Several H. pylori virulence factors such as vacA
toxin may interfere with protective immunity by acting on professional
antigen-presenting cells (APCs) impairing their antigen processing
capability and subsequently modulating immune response to H. pylori
infection [72]. The failure to clear H. pylori infection from the gastric
mucosa almost invariably leads to chronic gastritis in infected patients.
Gastritc colonization of H. pylori infection in human is followed by
gastric mucosal inﬂammation, which varies depending on the host
immune response against this bacterium [73]. In infected patients, H.
pylori virulence factors such as NAP, VacA cytotoxin or CagA protein,
and urease are allowed to cross the damaged layer of gastric cells and to
induce chemotaxis and activation of human neutrophils and monocytes.
For example, H. pylori-induced CXCL8/IL-8 production by gastric epi-
thelial cells plays a central role in the initial host immune response to
this bacterium; because IL-8 is a strong chemotactic and activating
N. Bagheri et al. Microbial Pathogenesis 123 (2018) 1–8
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factor for neutrophils, which in turn contribute to increasing the in-
ﬂammatory response [74]. When macrophages are recruited to sites of
infection and exposed to inﬂammatory stimuli, they secrete cytokines,
such as IL-1, IL-6, TNF-α, IL-12, IFN-γ, and chemokines, such as IL-8
(Fig. 3). Recruited neutrophils in gastric mucosa can also produce IL-12
in response to bacterial antigens [75]. This is an essential step in the
natural history of infected patients with H. pylori, because the local
cytokine milieu, particularly IL-12 produced by neutrophils and mac-
rophages of the natural immunity, is essential to drive the subsequent
speciﬁc CD4+ T-cell response into a more or less Th1-polarized immune
response (Fig. 3). CD3+CD4+ T cells increase in gastric lamina propria
(LP) of patients infected with H. pylori and play important roles in the
Fig. 2. The role of CD4+ T-cell subpopulations derived cytokines in generation of macrophage subpopulations and consequences of their activation.
Fig. 3. Helicobacter pylori, its interaction with immune cells, and immune pathogenesis of gastric mucosa damage. Virulence factors of H. pylori activate the innate
immune system cells (neutrophil, dendritic cells (DCs) and M1 macrophage) in gastric mucosa of infected patients. Activation of neutrophil, DC and M1 macrophage
can lead to important antimicrobial eﬀects but can also result in inﬂammation and tissue injury due to release of inﬂammatory mediators such as TNF-α, IL-8, IL-6, IL-
12 and IL-23, reactive oxygen species (ROS), and nitric oxide (NO). The release of inﬂammatory mediators induces the preferential development of H. pylori-speciﬁc
Th1/Th17 cell responses. Reactive oxygen (RO) and NO species from neutrophils and M1 macrophage cells increase the oxidative stress that together with other
immune-mediated mechanisms, induce apoptosis of the epithelium. In addition, oxidative stress can damage DNA, leading to the disruption of gene function. Thus,
the longer the period of exposure of a tissue to activated immune/inﬂammatory cells and mediators, the more cellular damage may accumulate.
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pathogenesis of persistent infection [76,77]. Studies of host immune
responses to H. pylori infection have mainly focused on Th1, Th17, Th2
and Treg cells [1,2,78], and as mentioned before, it is usually ac-
knowledged that H. pylori infection results in a Th1-dominant immune
response and that gastric inﬂammation mainly depends on Th1 cell
immune responses [76,79]. Previous studies have shown that expres-
sion of IL-6, IL-23, IL-12 and TGF-β is elevated in the gastric mucosa of
patients with H. pylori infection [43,80–82]. Theis secretion of IL-6, IL-
23, IL-12 and TGF-β creates a cytokine milieu that facilitates the po-
larization of Treg and Th1/Th17 cells response to H. pylori infection.
Both Th1 and Th17 immune responses mediate mucosal inﬂammation
in infected patients with H. pylori (Fig. 3). In terms of the dynamics of T
CD4+ helper cell immune responses, it has been demonstrated that at
the early stage of infection Th17 cell responses are induced earlier than
Th1 cell responses, indicating that Th17 and Th1 cells may promote
gastric mucosal inﬂammation at diﬀerent stages. Currently, the re-
lationship between Th1 and Th17 cells in H. pylori infection is not ex-
actly clear. A study on mice model of H. pylori infection has demon-
strated that Th1 cell responses to H. pylori infection are signiﬁcantly
reduced in IL-17 knockout mice but the responses are not signiﬁcantly
diﬀerent between the IL-17 blockade and IL-17 overexpression models.
The inconsistency in the results regarding IL-17 knockout and IL-17
blocking model might be due to IL-17 activity not being absolutely
blocked when anti-IL-17 is used. These results have proposed that the
Th17/IL-17 pathway modiﬁes Th1 cell responses, and Th1 and
Th17 cell responses may act synergistically to induce gastric mucosal
inﬂammation during H. pylori infection [83]. A study with mice model
of H. felis infection also has shown that neutralization of IFN-γ sig-
niﬁcantly reduces the severity of gastric mucosal inﬂammation, which
strongly supporting the concept that preferential long-lasting activation
of a Th1 cell responses contributes to progress and maintenance of
gastric pathology [84].
Recent studies have shown that Tregs suppress the immune response
to H. pylori infection [85,86]. Accumulating evidence indicates that the
failure of the host to eradicate H. pylori may be due to the ability of the
pathogen to evade T cell immunity by inducing Tregs. Recent studies
have also shown that H. pylori-speciﬁc Tregs suppress memory T-cell
responses in infected patients [87,88]. Studies in mice infected with H.
pylori have shown that depletion of Tregs leads to increased gastric
inﬂammation and reduced colonization of H. pylori infection [85].
These ﬁndings suggest that Tregs contribute to the persistence of H.
pylori colonization in gastric mucosa. A study has conﬁrmed that the
number of Tregs and the expression of IL-10 and TGF-β1 are sig-
niﬁcantly higher in infected patients than in uninfected subjects.
Moreover, the number of Tregs and the expression of IL-10 and TGFβ1
are signiﬁcantly higher in infected patients with gastritis than in in-
fected patients with PUD [89], strongly supporting the concept that
Treg cell responses in infected patients with gastritis are capable of
modulating Th1 and Th17 cell responses that possibly contribute to the
persistence of H. pylori infection.
6. Th1-cells and peptic ulcer disease (PUD)
Infection of the gastric antrum by H. pylori represents a key factor in
the etiology of various gastrointestinal diseases, but the reason why
only a limited number (10–20%) of infected patients with H. pylori-
induced PUD undergo complications of the infection remains to be
clariﬁed. H. pylori infection itself can induce mucosal damage, and
some mechanisms of gastric mucosal damage may be correlated with
the virulence factors of H. pylori [90]. H. pylori and its antigens, such as
VacA, NAP or CagA, induce gastric epithelial cells to produce IL-8
[91–93]. H. pylori activates macrophages, and triggers IL-18, IL-12, and
IL-17 production [7,21,94]. IL-18 and IL-12 induce the preferential
development of H. pylori-speciﬁc Th1 cell responses. The T CD4+ cell
response polarizes more into the Th1 pattern with autocrine secretion
of IFN-γ [95]. TNF-α and IFN-γ secreted by chronically activated H.
pylori-speciﬁc CD4+ Th1 may lead to PUD because TNF-α and IFN-γ are
able to induce functional alterations of gastric epithelial cells, and
following increased gastric acid secretion (Fig. 3) [96].
Recent studies have shown that Th1 polarization of H. pylori-speciﬁc
T cell is related to more severe disease in infected patients [97–99]. The
theory that the Th1-type of gastric T cell response against H. pylori
infection contributes to the pathogenesis of PUD is indirectly supported
by an intersting observation that, in spite of a high frequency of H.
pylori colonization, PUD and active gastritis were almost absent in renal
allograft recipients undergoing strong T cell immunosuppression
therapy [100]. In agreement with above results, a recent study has
demonstrated that the frequencies of IL-17 A+ and IFN-γ+ cells are
signiﬁcantly higher in antrum biopsies of gastric ulcer (GU) patients
compared to H. pylori-infected non-ulcer dyspepsia patients. In addi-
tion, IL-17 A+ and IFN-γ+ cells are not detected in biopsies collected
from uninfected subjects. Moreover, the frequencies of IFN-γ+ and IL-
17 A+ cells are positively correlates with inﬂammation score but not
with reduced bacterial colonization in the antrum of H. pylori-infected
patient [101]. Another study in a mouse model with severe combined
immunodeﬁciency has shown that transferring T cells derived from H.
pylori infected patients into those mice induceed gastric ulcer, in-
dicating that host immune system is involved in the progression of PUD
[102]. ]. A study on mice infected with H. felis also demonstrated that
neutralization of IFNγ signiﬁcantly reduced inﬂammation in the sto-
mach, strongly supporting the idea that preferential long-lasting acti-
vation of a Th1 cell responses contributes to maintenance and devel-
opment of gastric pathology (Fig. 3). The magnitude of H. felis-induced
gastric inﬂammation has been observed to be higher in mouse IL-4 −/−
than in their wild-type counterparts. Furthermore, infection with H.
felis in BALB/c mice induced minimal gastric inﬂammation, whose
genetic background is prone to high IL-4 production in response to
various antigens of H. felis [84]. A recent study conﬁrmed that the
number of Treg cells and the expression of IL-10 and TGFβ1 were sig-
niﬁcantly lower in infected patients with PUD than in infected patients
with gastritis [89]. The results oﬀer further evidence that unlimited Th1
cell response is related to more severe gastroduodenal diseases (such as
PUD and GC) in infected patients with H. pylori, whereas a mixed Th1/
Th2 and Treg cells response is able to reduce the unbalanced Th1 cell
responses and result in less severe pathological consequences
[2,84,103].
7. Th1-cells and gastric cancer (GC)
GC is an important cause of mortality due to cancer and is estimated
to be one of the most leading causes of all deaths worldwide. Although
a number of factors are related to the development and progression of
GC, a relationship with chronic gastric inﬂammation has become evi-
dent in recent years [104], the precise mechanism of the development
of GC has not yet been elucidated [105]. In H. pylori-infection induced
chronic gastritis mucosa, the number of T CD4+ cells predominates
over other cell types of the immune system [106]. T CD4+ cells appear
to be essential for the development of gastritis because gastritis does not
develop in mice lacking T CD4+ cells [76]. In addition, the develop-
ment of gastritis by H. pylori-infection is impaired in IFN-γ-deﬁcient
mice, whereas IL-4 deﬁciency enhances the development of gastritis
[79]. Therefore, IFN-γ produced by Th1 cells plays an important role in
the development of gastritis. It has also been shown that those H. pylori-
speciﬁc T cells are responsible for the inﬁltration of neutrophils and
macrophage in the gastric mucosa [107]. In addition to the inﬁltration
of T cells and activated neutrophils and macrophage cells, H. pylori-
induced gastritis is characterized by the enhanced production of a
variety of pro-inﬂammatory cytokines IL-1β, IL-6, IL-8, and TNF-α have
been reported to increase in H. pylori-infected patients [81,108,109],
moreover, the major Th cells populations and their signature cytokines
are suggested to play important roles in cancer development
[110–112]. Chronic inﬂammation in infected patients with H. pylori
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causes damage to the host gastric mucosa, cell proliferation and cyto-
kine-induced DNA synthesis, hyperplasia and carcinogenesis [113],
which make the gastric cancer become a long and complicated process.
A recent study has shown that Th1 cell responses are expanded in GC
tissue or in peripheral blood mononuclear cell populations, and mainly
in lymph node metastasis of patients with GC. This data suggest that
Th1 cells inﬁltration may contribute to the GC development and me-
tastasis [114]. The studies using various mouse tumor models have
supported a role of Th1 cell responses in antitumor immune responses.
Th1 cell responses have been observed to exhibit a signiﬁcant in-
hibitory function in the development of metastatic disease, but not in
primary tumor in a mouse autochthonous prostate cancer model [115].
Th1 cell is required for adaptive immune responses against transplan-
table melanoma [116]. Surprisingly, Th1 (T-bet) deﬁciency has been
reported to prevent H. felis-induced GC [117]. It was shown that Th1 (T-
bet)-deﬁcient mice respond to H. felis infection with a blunted Th1 re-
sponse and a greatly reduced IL-1β and TNF-α but increased IL-10 le-
vels. This result is, however, not contradictory to the idea that T-bet
promotes antitumor immune responses. It is because in this case, the
main role of T-bet is to facilitate H. felis-driven inﬂammation which
precedes and is likely critical for gastric cancer development. Taken
together, IFN-γ plays an important role in the control of H. pylori in-
fection [118,119]. But, CD4+ T cell-derived IFN-γ provides the key
stimulus for development of gastric premalignant lesions that can
progress to GC [118].
8. Conclusions
Activation of the diﬀerent types of eﬀector T cells inﬂuences the
clinical outcome of H. pylori infection. H. pylori mediated im-
muopathology in gastric mucosal tissue of infected patients is asso-
ciated with an inﬂammatory response with signiﬁcant contribution of
Th1-dominant cell responses. Virulence factors of H. pylori via activa-
tion of innate immune cells and release of inﬂammatory cytokines in-
duce preferential development of H. pylori-speciﬁc Th1/Th17 cell re-
sponses. In this context increased Treg cell responses are capable of
modulating Th1 and Th17 cell responses that possibly contributes to the
persistence of H. pylori-infection and modulation of the tissue damage.
Therefore, uncontrolled Th1/Th17 cell responses and the decrease of
Treg cell responses in some infected patients might be associated with
the development of more severe H. pylori-related diseases including
PUD as a consequence of the induction of immunopathologic reactions.
There are contradictory results in relation to the protective adaptive
immunity of Th1/Th17 cell responses against H. pylori infection, which
should be further investigated. Modulation of the eﬀector CD4+ T cells
response to H. pylori-infection must be taken into consideration to de-
sign novel therapeutic strategies for the successful treatment of H. py-
lori-related complications.
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